We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
-10.74%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$389M
AUM Growth
-$64.4M
Cap. Flow
-$8.43M
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.99%
Holding
441
New
20
Increased
68
Reduced
75
Closed
17

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$2.58M
2
OKTA icon
Okta
OKTA
+$619K
3
SCHW
Charles Schwab
SCHW
+$514K
4
ADBE icon
Adobe
ADBE
+$512K
5
AMZN icon
Amazon
AMZN
+$477K

Top Sells

Rank Stock Value
1
DOV icon
Dover
DOV
+$371K
2
CHD icon
Church & Dwight Co
CHD
+$312K
3
BMY icon
Bristol-Myers Squibb
BMY
+$276K
4
IAU icon
iShares Gold Trust
IAU
+$265K
5
RMD icon
ResMed
RMD
+$202K

Sector Composition

Rank Sector Weight
1 Technology 23.48%
2 Healthcare 14.39%
3 Miscellaneous 14.13%
4 Consumer Staples 13.42%
5 Financials 11.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERF
351
DELISTED
Enerplus Corporation
ERF
$3K ﹤0.01%
200
BBC icon
352
Virtus Biotech Clinical Trials ETF
BBC
$50.6M
$2K ﹤0.01%
100
C icon
353
Citigroup
C
$223B
$2K ﹤0.01%
40
COIN icon
354
Coinbase
COIN
$47.1B
$2K ﹤0.01%
40
DNA icon
355
Ginkgo Bioworks
DNA
$469M
$2K ﹤0.01%
18
GNOM icon
356
Global X Genomics & Biotechnology ETF
GNOM
$92.3M
$2K ﹤0.01%
38
IWM icon
357
iShares Russell 2000 ETF
IWM
$80.8B
$2K ﹤0.01%
11
LUMN icon
358
Lumen
LUMN
$6.23B
$2K ﹤0.01%
142
NFLX icon
359
Netflix
NFLX
$340B
$2K ﹤0.01%
+100
New +$2.22K
PIO icon
360
Invesco Global Water ETF
PIO
$274M
$2K ﹤0.01%
70
CFMS
361
DELISTED
Conformis, Inc. Common Stock
CFMS
$2K ﹤0.01%
200
ACAD icon
362
Acadia Pharmaceuticals
ACAD
$5.02B
$1K ﹤0.01%
100
BKCH icon
363
Global X Blockchain ETF
BKCH
$261M
$1K ﹤0.01%
25
SRTA
364
Strata Critical Medical Inc
SRTA
$528M
$1K ﹤0.01%
125
EA
365
DELISTED
Electronic Arts
EA
$1K ﹤0.01%
5
FARO
366
DELISTED
Faro Technologies
FARO
$1K ﹤0.01%
+30
New +$1.1K
GDRX icon
367
GoodRx Holdings
GDRX
$1.2B
$1K ﹤0.01%
191
GFI icon
368
Gold Fields
GFI
$40.9B
$1K ﹤0.01%
+105
New +$1.25K
GH icon
369
Guardant Health
GH
$21.7B
$1K ﹤0.01%
20
KOMP icon
370
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.67B
$1K ﹤0.01%
37
LYFT icon
371
Lyft
LYFT
$6.7B
$1K ﹤0.01%
100
DFTX
372
Definium Therapeutics
DFTX
$5.51B
$1K ﹤0.01%
67
OXY.WS icon
373
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$1K ﹤0.01%
27
SCHA icon
374
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$1K ﹤0.01%
+64
New +$1.37K
TTWO icon
375
Take-Two Interactive
TTWO
$44B
$1K ﹤0.01%
+5
New +$636

Similar funds

American Research & Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, American Research & Management Company held 441 positions worth $389M, down 14% from $454M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

American Research & Management Company's Q2 2022 filing shows 20 new, 68 increased, 75 reduced and 17 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,810 shares worth $369K. The largest sale was Dover, an estimated $371K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Miscellaneous.

  • American Research & Management Company's largest Q2 2022 buy was Vanguard Short-Term Bond ETF: 4,810 shares worth $369K.
  • American Research & Management Company added most to Freeport-McMoran in Q2 2022, an estimated $2.58M increase.
  • American Research & Management Company's biggest Q2 2022 reduction was Dover, cutting an estimated $371K.
  • American Research & Management Company fully exited Unifirst Corp in Q2 2022, selling an estimated $110K.
  • American Research & Management Company's ten largest holdings make up 32% of its $389M portfolio in Q2 2022.
  • American Research & Management Company opened 20 new positions and closed 17 in Q2 2022.
  • American Research & Management Company's portfolio value fell 14% quarter-over-quarter to $389M.

Based on American Research & Management Company's 13F filing for Q2 2022, filed 22 Jul 2022.